Clinical trial

CF101 Therapy Compared to Methotrexate Therapy for Active Rheumatoid Arthritis

NCT02647762

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2017-10-30

PhasePHASE3

Study timeline

Study start (actual)2017-10-30Date precision: day

Registry last updated2020-12-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Rheumatoid Arthritisunresolved

Interventions

CF101 1 mgDRUG

CF101 2 mgDRUG

PlaceboDRUG

MTXDRUG

Sponsors & collaborators

Can-Fite BioPharmalead sponsor

Mapped research locations

BucharestRomania6 PoznanPoland1 HaifaIsrael1 BialystokPoland1 BelgradeSerbia1 IașiRomania1 TimișoaraRomania1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02647762 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.